Industry Perspectives

Passive, low-latency monitoring for IoMT devices to spot firmware tampering, ransomware, lateral movement, and protect patient care.

Practical guide to cross-border AI telemedicine compliance: data mapping, lawful transfers, vendor oversight, human review, and technical controls.

Encrypt ePHI across layers - TLS 1.3, AES-GCM, ECC/RSA, IPsec, and S/MIME - with strict key management for HIPAA compliance.

Step-by-step checklist to verify vendor access: inventory, MFA, RBAC, JIT, logging, offboarding SLAs, and PHI controls.

Default to TLS 1.3 + ECDHE for portals/APIs, use mTLS for system links, keep RSA for legacy, and pilot post‑quantum for long‑term PHI.

Contain threats in minutes: revoke compromised identities, microsegment workloads, and keep EHRs online while limiting PHI exposure.

Drills only matter if you score them: 12 metrics tie detection, clinical impact, communications, cost, and action closure to patient safety.

Vendor access, APIs, and weak identity controls make healthcare supply chains vulnerable; focus on who, how they log in, and access duration.

How ransomware and device outages create patient-safety risks and trigger HIPAA, CMS, FDA, and state compliance actions.

Map vendor and fourth‑party links, align joint recovery playbooks, monitor continuously, and enforce recovery contract terms.

FDA cyber-device compliance lifecycle: scope, SBOM, threat→control→test traceability, eSTAR submission, postmarket monitoring.

Checklist: identify unsecured PHI, document the four-factor risk review, and meet HIPAA and state breach-notification deadlines.

Civil HIPAA penalties target organizations for compliance failures; criminal penalties target individuals for knowing PHI misuse.

Chatbot and virtual assistant vendors pose critical PHI risks — healthcare organizations must enforce strict vendor risk management and HIPAA safeguards.

Guidance on HIPAA-compliant AI data governance: privacy, de-identification, security controls, vendor risk management, and ongoing monitoring.

Concise guide to FDA pathways, required evidence, and postmarket controls for AI/ML medical devices (510(k), De Novo, PMA, PCCP).

Explains how PKI secures PHI with keys, certificates, CAs, revocation, HSMs, and automated lifecycle management.

AES-256 at rest, TLS 1.3 in transit, separate KMS/HSM key control, immutable copies and tested restores to meet HIPAA and cut breach risk.

De-identification must be a repeatable process: choose Safe Harbor or Expert Determination, remove hidden PHI, and retest re-identification risk.

Healthcare vendor risk needs a repeatable PHI-aware process: one inventory, PHI/clinical tiering, scoring, remediation, and contract terms.

How HDO type shapes vendor risk metrics—scope, compliance, clinical impact, and governance for IDNs, AMCs, regional, and specialty systems.

HDO guide to securing API gateways: edge token validation, scoped FHIR access, mTLS, schema checks, rate limits, and audit logging.

Score medical-device cyber risks by exploitability and patient impact; document pre/post-mitigation and maintain traceable QMS records.

Four-step framework to inventory, test, secure, and trace firmware—link findings to risk records for safer, compliant medical devices.